Annals of Oncology Advance Access published online on November 5, 2009
Annals of Oncology, doi:10.1093/annonc/mdp497
© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
letter to the editor |
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients
| The first 10% of the full text of this article appears below. |
More than 30%–50% of women at breast cancer diagnosis are vitamin D deficient. The importance of preserving bone health in survivors of breast cancer has gained predominant priority because these women have higher than average rates of bone loss and fracture as they age and they have a 15% higher fracture risk
disclosure
1 Department of Medical Oncology
2 Department of Clinical Pathology, University Campus Bio-Medico, Rome
3 Department of Clinical Biochemistry, University of Verona, Verona
4 Breast Surgery Unit, University Campus Bio-Medico, Rome
5 Department of Biomedical and Surgical Sciences, Unit of Diseases of Mineral Metabolism and the Bone, University of Verona, Verona, Italy
* (E-mail: g.tonini@unicampus.it)